3,5,8-TMON for COVID-19

3,5,8-TMON has been reported as potentially beneficial for COVID-19 in the following study.

COVID-19 involves the interplay of 350+ viral and host proteins and factors providing many therapeutic targets. Scientists have proposed 10,000+ potential treatments. c19early.org analyzes 210+ treatments. We have not reviewed 3,5,8-TMON in detail.

Study suggesting benefit with 3,5,8-TMON

Moraes et al., Naphthoquinone derivatives as potential immunomodulators: prospective for COVID-19 treatment, RSC Advances, doi:10.1039/d3ra08173g

The microbial naphthoquinone 3,5,8-TMON and its derivatives showed great anti-inflammatory activity, regulating cytokines and with promising activity mitigating COVID-19 inflammatory impacts.